1. Two-way remote monitoring allows effective and realistic provision of home-NIV to COPD patients with persistent hypercapnia
- Author
-
Karok S, M Sumowski, O'Dwyer C, David J Lowe, Grace McDowell, Hannah Toellner, C Carlin, and Hornsby J
- Subjects
medicine.medical_specialty ,COPD ,business.industry ,Copd patients ,Hypercapnic respiratory failure ,medicine.disease ,Service model ,Emergency medicine ,Cohort ,Breathing ,Medicine ,medicine.symptom ,business ,Hypercapnia ,Respiratory care - Abstract
Background Outcomes for chronic obstructive pulmonary disease (COPD) patients with persistent hypercapnic respiratory failure are improved by long-term home non-invasive ventilation (NIV). Provision of home-NIV presents clinical and service challenges. The aim of this study was to assess outcomes of home-NIV in hypercapnic COPD patients managed remotely. Methods Retrospective analysis of a dataset of 46 COPD patients with persistent hypercapnic respiratory failure who commenced home-NIV managed by two-way remote monitoring (Lumis, AirView, ResMed) between February 2017 and January 2018. The primary outcome of this study was time to readmission or death at 12 months in patients receiving home-NIV versus a retrospectively identified control cohort of 27 patients with hypercapnic COPD who had not been referred for home-NIV. Results The median time to readmission or death was significantly prolonged in patients who commenced home-NIV (median 160 days, 95% CI 69.38-250.63) versus the control cohort (66 days, 95% CI 21.9-110.1; p Conclusion These findings confirm the benefits of home-NIV in clinical practice and support the use of two-way remote monitoring as a feasible solution to managing the delivery of home-NIV for COPD patients with persistent hypercapnia. KEY MESSAGES What is the key question? Do COPD patients with persistent hypercapnia benefit from remotely monitored home-NIV? What is the bottom line? Home-NIV supported with two-way remote monitoring prolonged time to readmission or death within 12 months in patients with hypercapnic COPD. Why read on? This is the first study to show that two-way remote monitoring can be an effective and realistic solution in providing access to home-NIV for COPD patients at the necessary scale. The COVID-19 pandemic has mandated remote-management for respiratory care where feasible. This study demonstrates feasibility, safety and efficacy of a remote-management service model for COPD-NIV and provides playbook for adoption by other clinical teams.
- Published
- 2020